We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effect of Crocus sativus (Saffron) Intake on Top of Standard Treatment, on Disease Outcomes and Comorbidities in Patients with Rheumatic Diseases: Synthesis without Meta-Analysis (SWiM) and Level of Adherence to the CONSORT Statement for Randomized Controlled Trials Delivering Herbal Medicine Interventions
- Authors
Tsiogkas, Sotirios G.; Grammatikopoulou, Maria G.; Gkiouras, Konstantinos; Zafiriou, Efterpi; Papadopoulos, Iordanis; Liaskos, Christos; Dardiotis, Efthimios; Sakkas, Lazaros I.; Bogdanos, Dimitrios P.
- Abstract
Rheumatic diseases (RDs) are often complicated by chronic symptoms and frequent side-effects associated with their treatment. Saffron, a spice derived from the Crocus sativus L. flower, is a popular complementary and alternative medicine among patients with RDs. The present systematic review aimed to summarize the available evidence regarding the efficacy of supplementation with saffron on disease outcomes and comorbidities in patients with RD diagnoses. PubMed, CENTRAL, clinicaltrials.gov and the grey literature were searched until October 2021, and relevant randomized controlled trials (RCTs) were screened for eligibility using Rayyan. Risk of bias was assessed using the Cochrane's Risk of Bias-2.0 (RoB) tool. A synthesis without meta-analysis (SWiM) was performed by vote counting and an effect direction plot was created. Out of 125 reports, seven fulfilled the eligibility criteria belonging to five RCTs and were included in the SWiM. The RCTs involved patients with rheumatoid arthritis, osteoarthritis and fibromyalgia, and evaluated outcomes related to pain, disease activity, depression, immune response, inflammation, oxidative stress, health, fatigue and functional ability. The majority of trials demonstrated some concerns regarding overall bias. Moreover, the majority of trialists failed to adhere to the formula elaborations suggested by the CONSORT statement for RCTs incorporating herbal medicine interventions. Standardization of herbal medicine confirms its identity, purity and quality; however, the majority of trials failed to adhere to these guidelines. Due to the great heterogeneity and the lack of important information regarding the standardization and content of herbal interventions, it appears that the evidence is not enough to secure a direction of effect for any of the examined outcomes.
- Subjects
DRUG therapy for rheumatism; ONLINE information services; META-synthesis; HERBAL medicine; MEDICINAL plants; SYSTEMATIC reviews; INGESTION; DIETARY supplements; RANDOMIZED controlled trials; TREATMENT effectiveness; FIBROMYALGIA; FLOWERS; OSTEOARTHRITIS; TUMOR necrosis factors; MEDLINE; COMORBIDITY; EVALUATION
- Publication
Nutrients, 2021, Vol 13, Issue 12, p4274
- ISSN
2072-6643
- Publication type
Article
- DOI
10.3390/nu13124274